A share price of Kestra Medical Technologies Ltd [KMTS] is currently trading at $27.32, up 0.63%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The KMTS shares have gain 4.39% over the last week, with a monthly amount glided 5.77%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Kestra Medical Technologies Ltd [NASDAQ: KMTS] stock has seen the most recent analyst activity on November 18, 2025, when BTIG Research initiated its Buy rating and assigned the stock a price target of $32. Previously, Wolfe Research started tracking the stock with Outperform rating on March 31, 2025, and set its price target to $29. On March 31, 2025, Wells Fargo initiated with a Overweight rating and assigned a price target of $28 on the stock. Stifel started tracking the stock assigning a Buy rating and suggested a price target of $28 on March 31, 2025. Piper Sandler initiated its recommendation with a Overweight and recommended $27 as its price target on March 31, 2025. Goldman started tracking with a Neutral rating for this stock on March 31, 2025, and assigned it a price target of $24. In a note dated March 31, 2025, BofA Securities initiated an Buy rating and provided a target price of $30 on this stock.
Kestra Medical Technologies Ltd experienced fluctuations in its stock price throughout the past year between $13.25 and $30.00. Currently, Wall Street analysts expect the stock to reach $28.25 within the next 12 months. Kestra Medical Technologies Ltd [NASDAQ: KMTS] shares were valued at $27.32 at the most recent close of the market. An investor can expect a potential return of 3.4% based on the average KMTS price forecast.
Analyzing the KMTS fundamentals
Trailing Twelve Months sales for Kestra Medical Technologies Ltd [NASDAQ:KMTS] were 74.26M which represents 53.40% growth. Gross Profit Margin for this corporation currently stands at 0.46% with Operating Profit Margin at -1.74%, Pretax Profit Margin comes in at -1.77%, and Net Profit Margin reading is -1.78%. To continue investigating profitability, this company’s Return on Assets is posted at -0.54, Equity is -1.89 and Total Capital is -0.61. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 26.72 points at the first support level, and at 26.11 for the second support level. However, for the 1st resistance point, the stock is sitting at 27.88, and for the 2nd resistance point, it is at 28.43.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Kestra Medical Technologies Ltd [NASDAQ:KMTS] is 5.47. Also, the Quick Ratio is 5.27, while the Cash Ratio stands at 4.91. Considering the valuation of this stock, the price to sales ratio is 21.47, the price to book ratio is 8.57.
Transactions by insiders
Recent insider trading involved COHEN RAYMOND W, Director, that happened on Mar 07 ’25 when 17000.0 shares were purchased.
